Book Profit on this NYSE-Listed Consumer Discretionary Stock: Bath & Body Works Inc

Aug 08, 2022 12:00 AM PDT | Team Kalkine
Book Profit on this NYSE-Listed Consumer Discretionary Stock: Bath & Body Works Inc


Bath & Body Works Inc

Company Overview:  Bath & Body Works, Inc. (NYSE: BBWI) is a specialty home fragrance and aromatic body care shop operating under the brands Bigelow and White Barn.  It operates 1,755 retail locations and online stores in North America. With more than 338 storefronts and 27 e-commerce sites, it also has the franchise, licensing, and wholesale agreements in place in roughly 35 additional countries. The firm sells its goods under a variety of brand names, including Bath & Body Works, White Barn, and Aromatherapy.

As per the previous report published on BBWI dated 07th June 2022, a ‘Buy’ stance was provided on the stock at USD 36.45 based on decent revenue performance, FY22 outlook, strong brand value, increased bottom-line, associated risks, and valuation with a target of USD 43.67 and the stock price has now moved by ~ 09.16% since then and the price has now moved close to the Resistance 1 and Resistance 2 levels.

Noted below are the details of support and resistance levels provided in our previous report:

Bath & Body Works Inc Chart

Considering the resistance, RSI trading around the overbought area, around 41.25% return in last month, current price levels, risks associated, and volatile market conditions on the back of rising interest rates, a ‘Sell’ rating is assigned to the “BBWI” at the current market price of USD 39.79, as of August 08, 2022, at 11:25 am PDT.  

Note: This report may be updated with details around fundamental and technical analysis, price/ chart in due course, as appropriate 

Note 1: Past performance is not a reliable indicator of future performance.

Note 2: The reference date for all price data, currency, technical indicators, support, and resistance levels is 04 August 2022. The reference data in this report has been partly sourced from REFINITIV.

Note 3: Investment decisions should be made depending on an individual's appetite for upside potential, risks, holding duration, and any previous holdings. An 'Exit' from the stock can be considered if the Target Price mentioned as per the Valuation and or the technical levels provided has been achieved and is subject to the factors discussed above.

Note 4: Target Price refers to a price level which the stock is expected to reach as per the relative valuation method and or technical analysis taking into consideration both short-term and long-term scenarios.

Note 5: ‘Kalkine reports are prepared based on the stock prices captured either from the New York Stock Exchange (NYSE), NASDAQ Capital Markets (NASDAQ), and or REFINITIV. Typically, all sources (NYSE, NASDAQ, or REFINITIV) may reflect stock prices with a delay which could be a lag of 15-20 minutes. There can be no assurance that future results or events will be consistent with the information provided in the report. The information is subject to change without any prior notice.’